The COVID-19 pandemic has brought fundamental changes to the practice of medicine As a more robust understanding of severe acute respiratory syndrome coronavirus 2 is elucidated, practices will require greater flexibility in order to adapt Antiseptics, such as povidone-iodine (PVP-I), are now routinely employed and will play a greater role in the future of healthcare Due to its ability to protect both patients and healthcare providers alike, PVP-I utilization, in the form of oral and nasal solutions, should be considered as an additional and expansive step in the standard precautions algorithm
Expanding the Role of Povidone-iodine in a COVID-19 Era